CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies

被引:1
作者
Richard, Jonathan [1 ,2 ]
Sannier, Geremy [1 ,2 ]
Zhu, Li [3 ]
Prevost, Jeremie [1 ,2 ]
Marchitto, Lorie [1 ,2 ]
Benlarbi, Mehdi [1 ,2 ]
Beaudoin-Bussieres, Guillaume [1 ,2 ]
Kim, Hongil [3 ]
Sun, Yaping [3 ]
Chatterjee, Debashree [1 ]
Medjahed, Halima [1 ]
Bourassa, Catherine [1 ]
Delgado, Gloria-Gabrielle [1 ]
Dube, Mathieu [1 ]
Kirchhoff, Frank [4 ]
Hahn, Beatrice H. [5 ,6 ]
Kumar, Priti [3 ]
Kaufmann, Daniel E. [7 ,8 ,9 ,10 ]
Finzi, Andres [1 ,2 ]
机构
[1] Ctr Rech CHUM, Montreal, PQ, Canada
[2] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA
[4] Ulm Univ, Med Ctr, Inst Mol Virol, Ulm, Germany
[5] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[6] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA USA
[7] Univ Montreal, Dept Med, Montreal, PQ, Canada
[8] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA
[9] Lausanne Univ Hosp, Dept Med, Div Infect Dis, Lausanne, Switzerland
[10] Univ Lausanne, Lausanne, Switzerland
来源
基金
加拿大健康研究院; 加拿大创新基金会; 美国国家卫生研究院;
关键词
HIV-1; ADCC; Env; nnAbs; bNAbs; hu-mice; A32; RNA-flow fish; IMMUNODEFICIENCY-VIRUS TYPE-1; CELLULAR CYTOTOXICITY ADCC; HIV-INFECTED CELLS; ENVELOPE GLYCOPROTEIN; EFFECTOR FUNCTION; CD4-BOUND CONFORMATION; VACCINE EFFICACY; MOLECULAR CLONES; DILEUCINE MOTIF; ANTI-CLUSTER;
D O I
10.1128/mbio.01827-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 envelope glycoprotein (Env) conformation substantially impacts antibody-dependent cellular cytotoxicity (ADCC). Envs from primary HIV-1 isolates adopt a prefusion "closed" conformation, which is targeted by broadly neutralizing antibodies (bnAbs). CD4 binding drives Env into more "open" conformations, which are recognized by non-neutralizing Abs (nnAbs). To better understand Env-Ab and Env-CD4 interaction in CD4+ T cells infected with HIV-1, we simultaneously measured antibody binding and HIV-1 mRNA expression using multiparametric flow cytometry and RNA flow fluorescent in situ hybridization (FISH) techniques. We observed that env mRNA is almost exclusively expressed by HIV-1 productively infected cells that already downmodulated CD4. This suggests that CD4 downmodulation precedes env mRNA expression. Consequently, productively infected cells express "closed" Envs on their surface, which renders them resistant to nnAbs. Cells recognized by nnAbs were all env mRNA negative, indicating Ab binding through shed gp120 or virions attached to their surface. Consistent with these findings, treatment of HIV-1-infected humanized mice with the ADCC-mediating nnAb A32 failed to lower viral replication or reduce the size of the viral reservoir. These findings confirm the resistance of productively infected CD4+ T cells to nnAbs-mediated ADCC and question the rationale of immunotherapy approaches using this strategy.IMPORTANCEAntibody-dependent cellular cytotoxicity (ADCC) represents an effective immune response for clearing virally infected cells, making ADCC-mediating antibodies promising therapeutic candidates for HIV-1 cure strategies. Broadly neutralizing antibodies (bNAbs) target epitopes present on the native "closed" envelope glycoprotein (Env), while non-neutralizing antibodies (nnAbs) recognize epitopes exposed upon Env-CD4 interaction. Here, we provide evidence that env mRNA is predominantly expressed by productively infected cells that have already downmodulated cell-surface CD4. This indicates that CD4 downmodulation by HIV-1 precedes Env expression, making productively infected cells resistant to ADCC mediated by nnAbs but sensitive to those mediated by bnAbs. These findings offer critical insights for the development of immunotherapy-based strategies aimed at targeting and eliminating productively infected cells in people living with HIV. Antibody-dependent cellular cytotoxicity (ADCC) represents an effective immune response for clearing virally infected cells, making ADCC-mediating antibodies promising therapeutic candidates for HIV-1 cure strategies. Broadly neutralizing antibodies (bNAbs) target epitopes present on the native "closed" envelope glycoprotein (Env), while non-neutralizing antibodies (nnAbs) recognize epitopes exposed upon Env-CD4 interaction. Here, we provide evidence that env mRNA is predominantly expressed by productively infected cells that have already downmodulated cell-surface CD4. This indicates that CD4 downmodulation by HIV-1 precedes Env expression, making productively infected cells resistant to ADCC mediated by nnAbs but sensitive to those mediated by bnAbs. These findings offer critical insights for the development of immunotherapy-based strategies aimed at targeting and eliminating productively infected cells in people living with HIV.
引用
收藏
页数:20
相关论文
共 109 条
[1]   Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection [J].
Abeynaike, Shawn A. ;
Huynh, Tridu R. ;
Mehmood, Abeera ;
Kim, Teha ;
Frank, Kayla ;
Gao, Kefei ;
Zalfa, Cristina ;
Gandarilla, Angel ;
Shultz, Leonard ;
Paust, Silke .
VIRUSES-BASEL, 2023, 15 (02)
[2]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[3]   Optimized Replicating Renilla Luciferase Reporter HIV-1 Utilizing Novel Internal Ribosome Entry Site Elements for Native Nef Expression and Function [J].
Alberti, Michael O. ;
Jones, Jennifer J. ;
Miglietta, Riccardo ;
Ding, Haitao ;
Bakshi, Rakesh K. ;
Edmonds, Tara G. ;
Kappes, John C. ;
Ochsenbauer, Christina .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (12) :1278-1296
[4]   An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity [J].
Alsahafi, Nirmin ;
Bakouche, Nordine ;
Kazemi, Mohsen ;
Richard, Jonathan ;
Ding, Shilei ;
Bhattacharyya, Sudipta ;
Das, Durba ;
Anand, Sai Priya ;
Prevost, Jeremie ;
Tolbert, William D. ;
Lu, Hong ;
Medjahed, Halima ;
Gendron-Lepage, Gabrielle ;
Delgado, Gloria Gabrielle Ortega ;
Kirk, Sharon ;
Melillo, Bruno ;
Mothes, Walther ;
Sodroski, Joseph ;
Smith, Amos B., III ;
Kaufmann, Daniel E. ;
Wu, Xueling ;
Pazgier, Marzena ;
Rouiller, Isabelle ;
Finzi, Andres ;
Munro, James B. .
CELL HOST & MICROBE, 2019, 25 (04) :578-+
[5]   Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity [J].
Alsahafi, Nirmin ;
Ding, Shilei ;
Richard, Jonathan ;
Markle, Tristan ;
Brassard, Nathalie ;
Walker, Bruce ;
Lewis, George K. ;
Kaufmann, Daniel E. ;
Brockman, Mark A. ;
Finzi, Andres .
JOURNAL OF VIROLOGY, 2016, 90 (06) :2993-3002
[6]   HIV-1 Vpu Antagonism of Tetherin Inhibits Antibody-Dependent Cellular Cytotoxic Responses by Natural Killer Cells [J].
Alvarez, Raymond A. ;
Hamlin, Rebecca E. ;
Monroe, Anthony ;
Moldt, Brian ;
Hotta, Mathew T. ;
Caprio, Gabriela Rodriguez ;
Fierer, Daniel S. ;
Simon, Viviana ;
Chen, Benjamin K. .
JOURNAL OF VIROLOGY, 2014, 88 (11) :6031-6046
[7]   Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity [J].
Arias, Juan F. ;
Heyer, Lisa N. ;
von Bredow, Benjamin ;
Weisgrau, Kim L. ;
Moldt, Brian ;
Burton, Dennis R. ;
Rakasz, Eva G. ;
Evans, David T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (17) :6425-6430
[8]   Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response [J].
Astorga-Gamaza, Antonio ;
Grau-Exposito, Judith ;
Burgos, Joaquin ;
Navarro, Jordi ;
Curran, Adria ;
Planas, Bibiana ;
Suanzes, Paula ;
Falco, Vicenc ;
Genesca, Meritxell ;
Buzon, Maria J. .
ELIFE, 2022, 11
[9]   Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption [J].
Bar, K. J. ;
Sneller, M. C. ;
Harrison, L. J. ;
Justement, J. S. ;
Overton, E. T. ;
Petrone, M. E. ;
Salantes, D. B. ;
Seamon, C. A. ;
Scheinfeld, B. ;
Kwan, R. W. ;
Learn, G. H. ;
Proschan, M. A. ;
Kreider, E. F. ;
Blazkova, J. ;
Bardsley, M. ;
Refsland, E. W. ;
Messer, M. ;
Clarridge, K. E. ;
Tustin, N. B. ;
Madden, P. J. ;
Oden, K. S. ;
O'Dell, S. J. ;
Jarocki, B. ;
Shiakolas, A. R. ;
Tressler, R. L. ;
Doria-Rose, N. A. ;
Bailer, R. T. ;
Ledgerwood, J. E. ;
Capparelli, E. V. ;
Lynch, R. M. ;
Graham, B. S. ;
Moir, S. ;
Koup, R. A. ;
Mascola, J. R. ;
Hoxie, J. A. ;
Fauci, A. S. ;
Tebas, P. ;
Chun, T-W .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) :2037-2050
[10]   Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique [J].
Baxter, Amy E. ;
Niessl, Julia ;
Fromentin, Remi ;
Richard, Jonathan ;
Porichis, Filippos ;
Massanella, Marta ;
Brassard, Nathalie ;
Alsahafi, Nirmin ;
Routy, Jean-Pierre ;
Finzi, Andres ;
Chomont, Nicolas ;
Kaufmann, Daniel E. .
NATURE PROTOCOLS, 2017, 12 (10) :2029-2049